Federal Register / Vol. 72, No. 226 / Monday, November 26, 2007 / Notices 65971 

the NIH will convene a Consensus 

Development Conference from February 

25–27, 2008, to assess the available 

scientific evidence related to the 

following questions: 

• What is the efficacy (results from 

clinical studies) of hydroxyurea 

treatment for patients who have sickle 

cell disease in three groups: Infants, 

preadolescents, and adolescents/adults? 

• What is the effectiveness (in 

everyday practice) of hydroxyurea 

treatment for patients who have sickle 

cell disease? 

• What are the short- and long-term 

harms of hydroxyurea treatment? 

• What are the barriers to 

hydroxyurea treatment (i.e., health care 

system factors and patient-related 

factors) for patients who have sickle cell 

disease and what are the potential 

solutions? 

• What are the future research needs? 

An impartial, independent panel will 

be charged with reviewing the available 

published literature in advance of the 

conference, including a systematic 

literature review commissioned through 

the Agency for Healthcare Research and 

Quality. The first day and a half of the 

conference will consist of presentations 

by expert researchers and practitioners 

and open public discussions. On 

Wednesday, February 27, the panel will 

present a statement of its collective 

assessment of the evidence to answer 

each of the questions above. The panel 

will also hold a press conference to 

address questions from the media. The 

draft statement will be published online 

later that day, and the final version will 

be released approximately six weeks 

later. The primary sponsors of this 

meeting are the NIH National Heart, 

Lung, and Blood Institute and the NIH 

Office of Medical Applications of 

Research. 

Advance information about the 

conference and conference registration 

materials may be obtained from 

American Institutes for Research of 

Silver Spring, Maryland, by calling 888–

644–2667 or by sending e-mail to 

consensus@mail.nih.gov. American 

Institutes for Research’s mailing address 

is 10720 Columbia Pike, Silver Spring, 

MD 20901. Registration information is 

also available on the NIH Consensus 

Development Program Web site at 

http://consensus.nih.gov. 

Please Note: The NIH has instituted 

security measures to ensure the safety of NIH 

employees and property. All visitors must be 

prepared to show a photo ID upon request. 

Visitors may be required to pass through a 

metal detector and have bags, backpacks, or 

purses inspected or x-rayed as they enter NIH 

buildings. For more information about the 

new security measures at NIH, please visit 

the Web site at http://www.nih.gov/about/ 

visitorsecurity.htm. 

Dated: November 14, 2007. 

Raynard S. Kington, 

Deputy Director, National Institutes of Health. 

[FR Doc. E7–22907 Filed 11–23–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center on Minority Health and 

Health Disparities; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center on 

Minority Health and Health Disparities 

Special Emphasis Panel, R13 Conference 

Grant Review. 

Date: December 19, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6707 

Democracy Blvd., Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Lorrita Watson, PhD., 

National Center on Minority Health and 

Health Disparities, National Institutes of 

Health, 6707 Democracy Blvd, Suite 800, 

Bethesda, MD 20892–5465, (301) 402–1366, 

watsonl@mail.nih.gov. 

Dated: November 16, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5810 Filed 11–23–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center on Minority Health and 

Health Disparities; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center on 

Minority Health and Health Disparities 

Special Emphasis Panel, Community Based 

Participatory Research (CBPR) Meeting. 

Date: December 16–18, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington DC 20015. 

Contact Person: Robert Nettey, MD., 

Scientific Review Administrator, National 

Institute on Minority Health and Health 

Disparities, 6707 Democracy Blvd., Suite 800, 

Bethesda, MD 20892, (301)–496–3996. 

Dated: November 16, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5811 Filed 11–23–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

mstockstill on PROD1PC66 with NOTICES